BHB810

· BigHat Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BHB810, covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma [Phase 1, Phase 2]